Quinn, T. J., Yuan, Z., Adem, A., Geha, R., Vrikshajanani, C., Koba, W., . . . Libutti, S. K. (2012). Pasireotide (SOM230) is Effective for the Treatment of Pancreatic Neuroendocrine Tumors (PNETs) in a Multiple Endocrine Neoplasia Type 1 (MEN1) Conditional Knockout Mouse Model.
Citação norma ChicagoQuinn, Thomas J., et al. Pasireotide (SOM230) Is Effective for the Treatment of Pancreatic Neuroendocrine Tumors (PNETs) in a Multiple Endocrine Neoplasia Type 1 (MEN1) Conditional Knockout Mouse Model. 2012.
Citação norma MLAQuinn, Thomas J., et al. Pasireotide (SOM230) Is Effective for the Treatment of Pancreatic Neuroendocrine Tumors (PNETs) in a Multiple Endocrine Neoplasia Type 1 (MEN1) Conditional Knockout Mouse Model. 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.